CEP
AMAG

Chicago Equity Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Chicago Equity Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-70,180
Closed -$1.29M – 850
2017
Q2 		$1.29M Buy
+70,180
New +$1.39M 0.03% 455

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Chicago Equity Partners's AMAG Position: Q3 2017 in Review

Chicago Equity Partners sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 70,180 shares — an estimated $1.29M sold.

Chicago Equity Partners first reported a position in AMAG in Q2 2017 and held it in 1 quarter. The position peaked at $1.29M in Q2 2017. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • Chicago Equity Partners reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Chicago Equity Partners sold 70,180 AMAG Pharmaceuticals shares in Q3 2017, an estimated $1.29M.
  • Chicago Equity Partners first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 1 quarter.
  • Chicago Equity Partners's AMAG Pharmaceuticals position peaked at $1.29M in Q2 2017.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on Chicago Equity Partners's 13F filing for Q3 2017, filed 1 Nov 2017.